摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

吡咯-3-硼酸频哪醇酯 | 214360-77-7

中文名称
吡咯-3-硼酸频哪醇酯
中文别名
1H-吡咯-3-基硼酸嚬哪醇酯
英文名称
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole
英文别名
pyrrole-3-boronic acid pinacol ester
吡咯-3-硼酸频哪醇酯化学式
CAS
214360-77-7
化学式
C10H16BNO2
mdl
MFCD11109266
分子量
193.054
InChiKey
VLOXXHSBLUSPCW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    77-79 °C
  • 沸点:
    311 °C
  • 密度:
    1.04
  • 闪点:
    142 °C

计算性质

  • 辛醇/水分配系数(LogP):
    2.91
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    34.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:4918d1bcd27218a8f07b1a1e3c3abdb5
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Pyrrole-3-boronic acid, pinacol ester
Synonyms: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Pyrrole-3-boronic acid, pinacol ester
CAS number: 214360-77-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H16BNO2
Molecular weight: 193.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-溴-1-叔丁基吡唑并[3,4-d]嘧啶-4-胺吡咯-3-硼酸频哪醇酯四(三苯基膦)钯potassium carbonate 作用下, 以 1,4-二氧六环 为溶剂, 反应 0.25h, 以26%的产率得到1-(tert-butyl)-3-(1H-pyrrol-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
    参考文献:
    名称:
    基于吡唑并[3,4-d]嘧啶的蛋白激酶D抑制剂的设计,合成和生物学评估。
    摘要:
    蛋白激酶D(PKD)在各种癌症特征中的多重作用已被反复报道。因此,寻找新型PKD抑制剂及其作为抗肿瘤药的评价已引起了广泛的关注。在这项工作中,合成了新颖的基于吡唑并[3,4- d ]嘧啶的泛PKD抑制剂,其在位置1具有结构多样性,并对其生物学活性进行了评估。从3-IN-PP1(一种已知的PKD抑制剂,IC 50值在94-108 nM范围内)出发,发现化合物17m对PKD具有改善的生化抑制活性(IC 50 = 17-35 nM)。随后的细胞分析表明3-IN-PP1和17m抑制PKD依赖的cortactin磷酸化。此外,3-IN-PP1对PANC-1细胞显示出有效的抗增殖活性。最后,针对不同癌细胞系的筛选表明3-IN-PP1是一种有效且用途广泛的抗肿瘤药。
    DOI:
    10.1016/j.ejmech.2020.112638
  • 作为产物:
    描述:
    3-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)-1-[三s(1-甲基乙基)甲硅烷基]-1H-吡咯四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 2.25h, 以70%的产率得到吡咯-3-硼酸频哪醇酯
    参考文献:
    名称:
    钯(II)催化的C ?H激活级联序列的多杂环形成。
    摘要:
    多杂环存在于许多天然产物中,并且在功能材料和药物设计中是有用的部分。作为合成花粉生物碱的计划的一部分,已经开发了一种新型的钯(II)催化的CH活化策略来构建此类系统。从简单的1,3-二烯基取代的杂环开始,可以一步合成大量包含吡咯,吲哚,呋喃和噻吩部分的多环系统。
    DOI:
    10.1002/anie.201501037
点击查看最新优质反应信息

文献信息

  • Highly Efficient Monophosphine-Based Catalyst for the Palladium-Catalyzed Suzuki−Miyaura Reaction of Heteroaryl Halides and Heteroaryl Boronic Acids and Esters
    作者:Kelvin Billingsley、Stephen L. Buchwald
    DOI:10.1021/ja068577p
    日期:2007.3.1
    active and efficient catalyst system derived from a palladium precatalyst and monophosphine ligands 1 or 2 for the Suzuki-Miyaura cross-coupling reaction of heteroaryl boronic acids and esters has been developed. This method allows for the preparation of a wide variety of heterobiaryls in good to excellent yields and displays a high level of activity for the coupling of heteroaryl chlorides as well as
    已经开发了一种高活性和高效的催化剂体系,该体系源自钯预催化剂和单膦配体 1 或 2,用于杂芳基硼酸和酯的 Suzuki-Miyaura 交叉偶联反应。该方法允许以良好到优异的产率制备多种杂二芳基化合物,并且对于杂芳基氯化物以及受阻芳基和杂芳基卤化物的偶联显示出高水平的活性。还研究了控制某些杂环基序转化效率的特定因素。
  • Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models
    作者:Ulrich Lücking、Lars Wortmann、Antje M. Wengner、Julien Lefranc、Philip Lienau、Hans Briem、Gerhard Siemeister、Ulf Bömer、Karsten Denner、Martina Schäfer、Marcus Koppitz、Knut Eis、Florian Bartels、Benjamin Bader、Wilhelm Bone、Dieter Moosmayer、Simon J. Holton、Uwe Eberspächer、Joanna Grudzinska-Goebel、Christoph Schatz、Gesa Deeg、Dominik Mumberg、Franz von Nussbaum
    DOI:10.1021/acs.jmedchem.0c00369
    日期:2020.7.9
    instability, selective ATR inhibition has been recognized as a promising new approach in cancer therapy. We now report the identification and preclinical evaluation of the novel, clinical ATR inhibitor BAY 1895344. Starting from quinoline 2 with weak ATR inhibitory activity, lead optimization efforts focusing on potency, selectivity, and oral bioavailability led to the discovery of the potent, highly selective
    ATR激酶通过激活DNA损伤修复的基本信号通路,特别是对复制压力的响应,在DNA损伤应答中起关键作用。由于DNA损伤和复制压力是基因组不稳定的主要来源,因此选择性ATR抑制已被认为是癌症治疗中一种有希望的新方法。现在,我们报告新颖的临床ATR抑制剂BAY 1895344的鉴定和临床前评估。从喹啉2开始由于ATR抑制活性较弱,针对效价,选择性和口服生物利用度的前导优化工作导致发现了有效的,高选择性的,口服的ATR抑制剂BAY 1895344,在携带某些DNA损伤的癌症异种移植模型中显示出强大的单一疗法功效维修缺陷。此外,BAY 1895344与某些诱导DNA损伤的化学疗法联合治疗可产生协同的抗肿瘤活性。BAY 1895344目前正在对晚期实体瘤和淋巴瘤(NCT03188965)的患者进行临床研究。
  • [EN] NEW MACROCYCLIC LRRK2 KINASE INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS MACROCYCLIQUES DE LA LRRK2 KINASE
    申请人:SERVIER LAB
    公开号:WO2021224320A1
    公开(公告)日:2021-11-11
    Compounds of formula (I): wherein R, X1, X2, X3, Z1, Z2, Z3, A and Ra are as defined in the description. Medicaments.
    式(I)的化合物:其中R、X1、X2、X3、Z1、Z2、Z3、A和Ra的定义如描述中所述。药物。
  • 유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
    申请人:Solus Advanced Materials co., Ltd. 솔루스첨단소재 주식회사(120190660630) Corp. No ▼ 214911-0058927BRN ▼668-81-01406
    公开号:KR20160076931A
    公开(公告)日:2016-07-01
    본 발명은 정공수송능, 발광능이 우수한 신규의 화합물 및 이를 하나 이상의 유기물층에 포함함으로써 발광효율, 구동 전압, 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.
    本发明涉及一种有着优异的载流子输运能力和发光性能的新型化合物,以及将其包含在一个或多个有机层中以提高有机电界发光器件的发光效率、驱动电压、寿命等特性。
  • Iridium-catalyzed C–H coupling reaction of heteroaromatic compounds with bis(pinacolato)diboron: regioselective synthesis of heteroarylboronates
    作者:Jun Takagi、Kazuaki Sato、John F Hartwig、Tatsuo Ishiyama、Norio Miyaura
    DOI:10.1016/s0040-4039(02)01135-8
    日期:2002.8
    The C–H coupling of aromatic heterocycles with bis(pinacolato)diboron was carried out in octane at 80–100°C in the presence of a 1/2[IrCl(COD)]2-(4,4′-di-tert-butyl-2,2′-bipyridine) catalyst (3 mol%). The reactions of five-membered substrates such as thiophene, furan, pyrrole, and their benzo-fused derivatives exclusively produced 2-borylated products, whereas those of six-membered heterocycles including
    芳香族杂环与双(频哪醇)二硼烷的C–H偶联是在80–100°C的辛烷中,在存在1/2 [IrCl(COD)] 2-(4,4'-二酯的条件下进行的-2,2'-联吡啶-丁基)催化剂(3mol%)。五元底物(例如噻吩,呋喃,吡咯及其苯并稠合衍生物)的反应仅生成2硼化产物,而六元杂环(包括吡啶和喹啉)的反应则选择性地在3位发生。还通过使用几乎等摩尔量的底物和二硼来实现双(硼基)杂芳族化合物的区域选择性合成。
查看更多